Skip to main content

Table 4 Morbidity and mortality

From: Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer

 

NACT (%)

n = 110

SURG (%)

n = 267

P value

Patients with complications

11(10.0%)

46(17.2%)

0.075

Postoperative LOS (days)

11.0 ± 4.7(5-40)

13 ± 8.9(6-79)

0.015

Postoperative LOS with complications (days)

16.8 ± 10.9(7-40)

24.0 ± 16.4(6-79)

0.174

Postoperative LOS without complications (days)

10.4 ± 2.8(5-19)

10.4 ± 3.1(6-27)

0.952

Nonsurgical complications

   

Pneumonia

1(0.9%)

4(1.5%)

1.000

Pleural effusion

2(1.8%)

2(0.7%)

0.583

gastric motility disorder

2(1.8%)

10(3.7%)

0.521

Mental status changes

0(0.0%)

1(0.4%)

1.000

Others (Diarrhea, Hiccup,

0(0.0%)

4(1.5%)

0.326

Thrombocytopenia) No. of patients

4(3.6%)

21(7.9%)

0.134

Surgical complications

   

Anastomotic leak

2(1.8%)

9(3.4%)

0.520

Intra-abdominal abscess

3(2.7%)

8(3.0%)

1.000

Postoperative bowel obstruction/ileus

2(1.8%)

3(1.1%)

0.631

Postoperative hemorrhage

0(0.0%)

4(1.5%)

0.326

Wound infection

0(0.0%)

2(0.7%)

1.000

No. of patients

7(6.4%)

26(9.7%)

0.292

Reexploration

1(0.9%)

9(3.4%)

0.292

Mortality

0(0.0%)

2(0.7%)

1.000

  1. LOS = length of stay; NS = not significant